With seven winners of four tickets each, all proceeds to benefit its Center for Cancer and Blood Disorders
NEW ORLEANS – Children’s Hospital New Orleans is grateful to have the opportunity to raise important funds for the hospital’s Center for Cancer and Blood Disorders as part of its 42nd annual Sugarplum Ball, through a ticket raffle for the Oct. 26, 2024, New Orleans TAYLOR SWIFT | THE ERAS TOUR.
Launching this week, Children’s Hospital New Orleans is offering a raffle for 28 suite tickets for the New Orleans TAYLOR SWIFT | THE ERAS TOUR. Participants will purchase chances to win tickets to see Taylor Swift perform live on Saturday, Oct. 26, 2024, in the Caesar’s Superdome in New Orleans. Tickets are $200 each with 5,000 maximum chances sold. Seven winners of four tickets each will be drawn and notified on Saturday, March 23, 2024.
“This is truly a once-in-a-lifetime opportunity, and for no greater cause,” said Children’s Hospital New Orleans President and CEO, Lucio A. Fragoso. “Raffle ticket sales will benefit the Center for Cancer and Blood Disorders at Children’s Hospital New Orleans, with proceeds being put to use immediately to help fund a new Pediatric Stem Cell Transplant Unit at Children’s Hospital. We are calling all swifties to join in and enter for your chances to win.”
The Center for Cancer and Blood Disorders at Children’s Hospital provides advanced treatments for children with leukemia, lymphoma, sickle cell anemia, hemophilia and other childhood cancers and blood disorders. Children’s Hospital is the only accredited pediatric stem cell transplant facility in the state, performing bone marrow transplants and CAR-T cell therapy. Children’s Hospital is also actively conducting cancer research at the forefront of medicine and has the largest, most experienced group of pediatric cancer specialists in the region, staffed by faculty from LSU Health New Orleans and Tulane University School of Medicine.
Patients undergoing stem cell transplantation are profoundly immunosuppressed and require prolonged hospital admissions that can last months. They are at high risk for infections and require enhanced protection while in the hospital. Pediatric Stem Cell Transplant Units are specially and expertly designed with children’s needs in mind and allow for play and socialization within the unit and outside their room because infection risks are minimized through the HEPA filtration system and separation from patients that may spread infections. This creates a much-improved patient experience, as stem cell transplant patients are often in the hospital for one to two months and sometimes longer.
Children’s Hospital cared for 20 transplant patients this year and expects this population to grow as the hospital continued to develop its Stem Cell Transplant and Cellular Therapy Program, including gene therapy for Sickle Cell disease patients which is now Food and Drug Administration (FDA) approved and will begin in 2024 as the only facility in Louisiana to offer this life-changing treatment.
All proceeds from the TAYLOR SWIFT | THE ERAS TOUR raffle will support this effort. To learn more, to purchase raffle tickets, and to read the official rules of participation, visit chnola.org/taylor.
###